{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:04:05Z","timestamp":1740107045706,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T00:00:00Z","timestamp":1649894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00520-022-07043-0","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T17:02:41Z","timestamp":1649955761000},"page":"6145-6153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between urine 6-sulfatoxy-melatonin level and intravesical Bacillus Calmette-Guerin treatment\u2013induced sleep quality deterioration in patients with non-muscle invasive bladder cancer"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9503-7356","authenticated-orcid":false,"given":"Makito","family":"Miyake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Oda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuki","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuto","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunta","family":"Hori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Morizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Anai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Torimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomomi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobumichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"key":"7043_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"7043_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL et al (2022) European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ). Eur Urol 81:75\u201394","journal-title":"Eur Urol"},{"key":"7043_CR3","doi-asserted-by":"crossref","unstructured":"Matsumoto H, Shiraishi K, Azuma H, Inoue K, Uemura H, Eto M et al (2020) Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: revision working position paper. Int J Urol 27:362\u2013368","DOI":"10.1111\/iju.14281"},{"key":"7043_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","volume":"18","author":"TW Flaig","year":"2020","unstructured":"Flaig TW, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK et al (2020) Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 18:329\u2013354","journal-title":"J Natl Compr Canc Netw"},{"key":"7043_CR5","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.eururo.2014.02.034","volume":"66","author":"JM Blazeby","year":"2014","unstructured":"Blazeby JM, Hall E, Aaronson NK, Lloyd L, Waters R, Kelly JD et al (2014) Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. Eur Urol 66:1148\u20131156","journal-title":"Eur Urol"},{"key":"7043_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.juro.2013.03.097","volume":"190","author":"P Gontero","year":"2013","unstructured":"Gontero P, Oderda M, Mehnert A, Gurioli A, Marson F, Lucca I et al (2013) The impact of intravesical gemcitabine and 1\/3 dose Bacillus Calmette-Guerin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial. J Urol 190:857\u2013862","journal-title":"J Urol"},{"key":"7043_CR7","first-page":"9480","volume":"25","author":"S Siracusano","year":"2018","unstructured":"Siracusano S, Silvestri T, Bassi S, Porcaro AB, Cerruto MA, Talamini R et al (2018) Health-related quality of life after BCG or MMC induction for non-muscle invasive bladder cancer. Can J Urol 25:9480\u20139485","journal-title":"Can J Urol"},{"key":"7043_CR8","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00520-021-06468-3","volume":"30","author":"M Miyake","year":"2022","unstructured":"Miyake M, Nishimura N, Oda Y, Owari T, Hori S, Morizawa Y et al (2022) Intravesical Bacillus Calmette-Guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer: functional outcome assessment based on a questionnaire survey and actigraphy. Support Care Cancer 30:887\u2013895","journal-title":"Support Care Cancer"},{"key":"7043_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/JU.0000000000000463","volume":"203","author":"JS Pesonen","year":"2020","unstructured":"Pesonen JS, Cartwright R, Vernooij RWM, Aoki Y, Agarwal A, Mangera A et al (2020) The impact of nocturia on mortality: a systematic review and meta-analysis. J Urol 203:486\u2013495","journal-title":"J Urol"},{"key":"7043_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1530\/ror.0.0030013","volume":"3","author":"J Arendt","year":"1998","unstructured":"Arendt J (1998) Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev Reprod 3:13\u201322","journal-title":"Rev Reprod"},{"key":"7043_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/1534735408322846","volume":"7","author":"V Srinivasan","year":"2008","unstructured":"Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Cardinali DP (2008) Therapeutic actions of melatonin in cancer: possible mechanisms. Integr Cancer Ther 7:189\u2013203","journal-title":"Integr Cancer Ther"},{"key":"7043_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12935-020-01531-1","volume":"20","author":"MH Mehrzadi","year":"2020","unstructured":"Mehrzadi MH, Hosseinzadeh A, Juybari KB, Mehrzadi S (2020) Melatonin and urological cancers: a new therapeutic approach. Cancer Cell Int 20:444","journal-title":"Cancer Cell Int"},{"key":"7043_CR13","doi-asserted-by":"publisher","first-page":"e12536","DOI":"10.1111\/jpi.12536","volume":"66","author":"YT Chen","year":"2019","unstructured":"Chen YT, Yang CC, Shao PL, Huang CR, Yip HK (2019) Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway. J Pineal Res 66:e12536","journal-title":"J Pineal Res"},{"key":"7043_CR14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/2211-5463.12223","volume":"7","author":"S Liu","year":"2017","unstructured":"Liu S, Liang B, Jia H, Jiao Y, Pang Z, Huang Y (2017) Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells. FEBS Open Bio 7:798\u2013810","journal-title":"FEBS Open Bio"},{"key":"7043_CR15","doi-asserted-by":"publisher","first-page":"175628722094087","DOI":"10.1177\/1756287220940870","volume":"12","author":"TC Cheng","year":"2020","unstructured":"Cheng TC, Lee YH, Chang YP, Lee DC (2020) Improved urinary melatonin level as the perspective indicator that leads to better sleeping quality in bladder cancer patients. Ther Adv Urol 12:1756287220940870","journal-title":"Ther Adv Urol"},{"key":"7043_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12885-021-07966-7","volume":"21","author":"M Miyake","year":"2021","unstructured":"Miyake M, Iida K, Nishimura N, Miyamoto T, Fujimoto K, Tomida R et al (2021) Non-maintenance intravesical Bacillus Calmette-Gu\u00e9rin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study. BMC Cancer 21:266","journal-title":"BMC Cancer"},{"key":"7043_CR17","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1007\/s00520-019-04709-0","volume":"27","author":"A Degboe","year":"2019","unstructured":"Degboe A, Ivanescu C, Rohay JM, Turner RR, Cella D (2019) Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients. Support Care Cancer 27:4189\u20134198","journal-title":"Support Care Cancer"},{"key":"7043_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S0959-8049(97)00395-X","volume":"34","author":"K Kobayashi","year":"1998","unstructured":"Kobayashi K, Takeda F, Teramukai S, Gotoh I, Sakai H, Yoneda S et al (1998) A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 34:810\u2013815","journal-title":"Eur J Cancer"},{"key":"7043_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1524-4733.2008.00449.x","volume":"12","author":"Y Tokuda","year":"2009","unstructured":"Tokuda Y, Okubo T, Ohde S, Jacobs J, Takahashi O, Omata F et al (2009) Assessing items on the SF-8 Japanese version for health-related quality of life: a psychometric analysis based on the nominal categories model of item response theory. Value Health 12:568\u2013573","journal-title":"Value Health"},{"key":"7043_CR20","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/jnci\/djn171","volume":"100","author":"ES Schernhammer","year":"2008","unstructured":"Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E et al (2008) Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 100:898\u2013905","journal-title":"J Natl Cancer Inst"},{"key":"7043_CR21","doi-asserted-by":"publisher","first-page":"5353","DOI":"10.1038\/s41598-017-05752-9","volume":"7","author":"J Xu","year":"2017","unstructured":"Xu J, Huang L, Sun GP (2017) Urinary 6-sulfatoxymelatonin level and breast cancer risk: systematic review and meta-analysis. Sci Rep 7:5353","journal-title":"Sci Rep"},{"key":"7043_CR22","volume-title":"Mixed-Effects Models in S and S-PLUS","author":"JC Pinheiro","year":"2002","unstructured":"Pinheiro JC, Bates DM (2002) Mixed-Effects Models in S and S-PLUS. Springer, New York"},{"key":"7043_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/187221411799015408","volume":"5","author":"V Srinivasan","year":"2011","unstructured":"Srinivasan V, Pandi-Perumal SR, Brzezinski A, Bhatnagar KP, Cardinali DP (2011) Melatonin, immune function and cancer. Recent Pat Endocr Metab Immune Drug Discov 5:109\u2013123","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"7043_CR24","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.3390\/jcm9072262","volume":"9","author":"T Olesen","year":"2020","unstructured":"Olesen T, Paul J, Gramme P, Drake MJ, Vandewalle J, Everaert K (2020) Assessment of the most impactful combination of factors associated with nocturia and to define nocturnal polyuria by multivariate modelling. J Clin Med 9:2262","journal-title":"J Clin Med"},{"key":"7043_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2265.1987.tb01172.x","volume":"27","author":"R Nowak","year":"1987","unstructured":"Nowak R, McMillen IC, Redman J, Short RV (1987) The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity. Clin Endocrinol (Oxf) 27:445\u2013452","journal-title":"Clin Endocrinol (Oxf)"},{"key":"7043_CR26","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.3390\/ijerph17061916","volume":"17","author":"B Rzepka-Migut","year":"2020","unstructured":"Rzepka-Migut B, Paprocka J (2020) Melatonin-measurement methods and the factors modifying the results. a systematic review of the literature. Int J Environ Res Public Health 17:1916","journal-title":"Int J Environ Res Public Health"},{"key":"7043_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7150\/oncm.25566","volume":"3","author":"S Liu","year":"2018","unstructured":"Liu S, Madu CO, Lu Y (2018) The role of melatonin in cancer development. Oncomedicine 3:37\u201347","journal-title":"Oncomedicine"},{"key":"7043_CR28","first-page":"560","volume":"52","author":"C Alonso-Gonzalez","year":"2018","unstructured":"Alonso-Gonzalez C, Menendez-Menendez J, Gonzalez-Gonzalez A, Gonzalez A, Cos S, Martinez-Campa C (2018) Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF7 human breast cancer cells. Int J Oncol 52:560\u2013570","journal-title":"Int J Oncol"},{"key":"7043_CR29","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1111\/j.1742-4658.2006.05322.x","volume":"273","author":"SR Pandi-Perumal","year":"2006","unstructured":"Pandi-Perumal SR, Sirinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B, Hardeland R (2006) Melatonin: Nature\u2019s most versatile biological signal? FEBS J 273:2813\u20132838","journal-title":"FEBS J"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07043-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-07043-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-07043-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T09:32:34Z","timestamp":1653557554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-07043-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["7043"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-07043-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2022,4,14]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol complied with the provisions of the Declaration of Helsinki. This study was conducted according to the Declaration of Helsinki (2013) and was approved by the Ethics Committee of the Nara Medical University (protocol ID: NMU-1719). Each enrolled patient provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}